Refractory subacute cutaneous lupus erythematous responding to a single course of belimumab: A new anti-BLyS human monoclonal antibody

被引：12
|
作者：
Husein-ElAhmed, Husein [1 ]
Luis Callejas-Rubio, Jose [1 ]
Rios-Fernandez, Raquel [1 ]
Ortego-Centeno, Norberto [1 ]
机构：
[1] San Cecilio Univ Hosp, Dept Dermatol, Unit Syst Dis, Granada, Spain
来源：
INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY | 2014年 / 80卷 / 05期
关键词：
D O I：
10.4103/0378-6323.140335
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：477 / U110
页数：2
相关论文
共 20 条
  • [1] Belimumab: Anti-BLyS human monoclonal antibody, anti-BLyS monoclonal antibody, BmAb, human monoclonal antibody to B-lymphocyte stimulator
    不详
    Drugs in R & D, 2008, 9 (3) : 197 - 202
  • [2] Belimumab - Anti-BLyS human monoclonal antibody, anti-BLyS monoclonal antibody, BmAb, human monoclonal antibody to B-lymphocyte stimulator
    不详
    DRUGS IN R&D, 2008, 9 (03) : 197 - 202
  • [3] Belimumab - an anti-BLyS human monoclonal antibody for rheumatoid arthritis
    Jin, Xingzhong
    Ding, Changhai
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (02) : 315 - 322
  • [4] Belimumab, an anti-BLyS human monoclonal antibody for potential treatment of inflammatory autoimmune diseases
    Ding, Changhai
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2008, 8 (11) : 1805 - 1814
  • [5] Belimumab: Anti-BLyS monoclonal antibody; Benlystatrade; BmAb; LymphoStat-B
    不详
    Drugs in R & D, 2010, 10 (1) : 55 - 65
  • [6] A Single-Arm, Phase II Study of the Anti-Blys Monoclonal Antibody Belimumab in Symptomatic Waldenstrom Macroglobulinemia
    Bishton, Mark
    Spencer, Andrew
    Dickinson, Michael
    Ritchie, David
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2013, 13 (05): : 575 - 578
  • [7] Long-term safety profile of belimumab (Fully human monoclonal antibody to BLyS) in patients with systemic lupus erythematosus
    Mckay, J.
    Merrill, J. T.
    Wallace, D. J.
    Furie, R.
    Stohl, W.
    Latinis, K.
    Wellborne, F.
    Wolfe, S.
    Angelly, T.
    Chen, A.
    Pineda, L.
    Hough, D.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S562 - S563
  • [8] Belimumab (Fully human monoclonal antibody to BLyS) improved or stabilized systemic lupus erythematosus (SLE) disease activity over 3 years of therapy
    Chatham, W.
    Furie, R.
    Petri, M.
    Ginzler, E. M.
    Wallace, D. J.
    Stohl, W.
    Strand, V.
    Weinstien, A.
    Zhong, J.
    Hough, D.
    Freimuth, W.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S573 - S574
  • [9] Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus
    Furie, Richard
    Stohl, William
    Ginzler, Ellen M.
    Becker, Michael
    Mishra, Nilamadhab
    Chatham, Winn
    Merrill, Joan T.
    Weinstein, Arthur
    McCune, W. Joseph
    Zhong, John
    Cai, Wendy
    Freimuth, William
    ARTHRITIS RESEARCH & THERAPY, 2008, 10 (05)
  • [10] Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus
    Richard Furie
    William Stohl
    Ellen M Ginzler
    Michael Becker
    Nilamadhab Mishra
    Winn Chatham
    Joan T Merrill
    Arthur Weinstein
    W Joseph McCune
    John Zhong
    Wendy Cai
    William Freimuth
    Arthritis Research & Therapy, 10
12